emerin and Muscular-Dystrophies

emerin has been researched along with Muscular-Dystrophies* in 61 studies

Reviews

11 review(s) available for emerin and Muscular-Dystrophies

ArticleYear
Using nuclear envelope mutations to explore age-related skeletal muscle weakness.
    Clinical science (London, England : 1979), 2020, 08-28, Volume: 134, Issue:16

    Skeletal muscle weakness is an important determinant of age-related declines in independence and quality of life but its causes remain unclear. Accelerated ageing syndromes such as Hutchinson-Gilford Progerin Syndrome, caused by mutations in genes encoding nuclear envelope proteins, have been extensively studied to aid our understanding of the normal biological ageing process. Like several other pathologies associated with genetic defects to nuclear envelope proteins including Emery-Dreifuss muscular dystrophy, Limb-Girdle muscular dystrophy and congenital muscular dystrophy, these disorders can lead to severe muscle dysfunction. Here, we first describe the structure and function of nuclear envelope proteins, and then review the mechanisms by which mutations in genes encoding nuclear envelope proteins induce premature ageing diseases and muscle pathologies. In doing so, we highlight the potential importance of such genes in processes leading to skeletal muscle weakness in old age.

    Topics: Aging; Humans; Lamin Type A; Membrane Proteins; Muscle Weakness; Muscle, Skeletal; Muscular Dystrophies; Mutation; Nuclear Envelope; Nuclear Proteins

2020
Lamina-associated polypeptide 1: protein interactions and tissue-selective functions.
    Seminars in cell & developmental biology, 2014, Volume: 29

    Mutations in genes encoding widely expressed nuclear envelope proteins often lead to diseases that manifest in specific tissues. Lamina-associated polypeptide 1 (LAP1) is an integral protein of the inner nuclear membrane that is expressed in most cells and tissues. Within the nuclear envelope, LAP1 interacts physically with lamins, torsinA and emerin, suggesting it may serve as a key node for transducing signals across the inner nuclear membrane. Indeed, recent in vivo studies in genetically modified mice strongly support functional links between LAP1 and both torsinA (in neurons) and emerin (in muscle). These studies suggest that tissue-selective diseases caused by mutations in genes encoding nuclear envelope proteins may result, at least in part, from the selective disruption of discrete nuclear envelope protein complexes.

    Topics: Animals; Carrier Proteins; Cytoskeletal Proteins; Humans; Lamins; Membrane Proteins; Mice; Molecular Chaperones; Muscular Dystrophies; Mutation; Nuclear Envelope; Nuclear Proteins; Signal Transduction

2014
Emerin and the nuclear lamina in muscle and cardiac disease.
    Circulation research, 2008, Jul-03, Volume: 103, Issue:1

    The human genome is contained within the nucleus and is separated from the cytoplasm by the nuclear envelope. Mutations in the nuclear envelope proteins emerin and lamin A cause a number of diseases including premature aging syndromes, muscular dystrophy, and cardiomyopathy. Emerin and lamin A are implicated in regulating muscle- and heart-specific gene expression and nuclear architecture. For example, lamin A regulates the expression and localization of gap junction and intercalated disc components. Additionally, emerin and lamin A are also required to maintain nuclear envelope integrity. Demonstrating the importance of maintaining nuclear integrity in heart disease, atrioventricular node cells lacking lamin A exhibit increased nuclear deformation and apoptosis. This review highlights the present understanding of lamin A and emerin function in regulating nuclear architecture, gene expression, and cell signaling and discusses putative mechanisms for how specific mutations in lamin A and emerin cause cardiac- or muscle-specific disease.

    Topics: Aging, Premature; Animals; Apoptosis; Atrioventricular Node; Cardiomyopathies; Gene Expression Regulation; Genome, Human; Humans; Lamin Type A; Membrane Proteins; Muscular Dystrophies; Mutation; Myocardium; Nuclear Lamina; Nuclear Proteins; Organ Specificity; Signal Transduction; Syndrome

2008
Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan.
    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology, 2007, Volume: 26, Issue:3

    Mutations in the genes for nuclear envelope proteins of emerin (EMD) and lamin A/C (LMNA) are known to cause Emery-Dreifuss muscular dystrophy (EDMD) and limb girdle muscular dystrophy (LGMD). We compared clinical features of the muscular dystrophy patients associated with mutations in EMD (emerinopathy) and LMNA (laminopathy) in our series. The incidence of laminopathy was slightly higher than that of emerinopathy. The age at onset of the disease in emerinopathy was variable and significantly older than in laminopathy. The initial symptom of emerinopathy was also variable, whereas nearly all laminopathy patients presented initially with muscle weakness. Calf hypertrophy was often seen in laminopathy, underscoring the importance of mutation screening for LMNA in childhood muscular dystrophy with calf hypertrophy. The clinical spectrum of emerinopathy is actually wider than previously known including EDMD, LGMD, conduction defects with minimal muscle/joint involvement, and their intermittent forms. Pathologically, no marked difference was observed between emerinopathy and laminopathy. Increased number and variation in size of myonuclei were detected. More precise observations using electron microscopy is warranted to characterize the detailed nuclear changes in nuclear envelopathy.

    Topics: DNA; Humans; Japan; Lamin Type A; Lipodystrophy; Membrane Proteins; Muscular Dystrophies; Mutation; Nuclear Envelope; Nuclear Proteins; Polymerase Chain Reaction; Prevalence

2007
The nuclear lamina comes of age.
    Nature reviews. Molecular cell biology, 2005, Volume: 6, Issue:1

    Many nuclear proteins form lamin-dependent complexes, including LEM-domain proteins, nesprins and SUN-domain proteins. These complexes have roles in chromatin organization, gene regulation and signal transduction. Some link the nucleoskeleton to cytoskeletal structures, ensuring that the nucleus and centrosome assume appropriate intracellular positions. These complexes provide new insights into cell architecture, as well as a foundation for the understanding of the molecular mechanisms that underlie the human laminopathies - clinical disorders that range from Emery-Dreifuss muscular dystrophy to the accelerated ageing seen in Hutchinson-Gilford progeria syndrome.

    Topics: Actins; Aging; Animals; Centrosome; Cytoskeleton; DNA-Binding Proteins; Humans; Lamins; Membrane Proteins; Muscular Dystrophies; Nuclear Lamina; Nuclear Proteins; Signal Transduction; Thymopoietins

2005
Nuclear membrane protein emerin: roles in gene regulation, actin dynamics and human disease.
    Novartis Foundation symposium, 2005, Volume: 264

    Loss of emerin, a nuclear membrane protein, causes Emery-Dreifuss muscular dystrophy (EDMD), characterized by muscle weakening, contractures of major tendons and potentially lethal cardiac conduction system defects. Emerin has a LEM-domain and therefore binds barrier-to-autointegration factor (BAF), a conserved chromatin protein essential for cell division. BAF recruits emerin to chromatin and regulates higher-order chromatin structure during nuclear assembly. Emerin also binds filaments formed by A-type lamins, mutations in which also cause EDMD. Other partners for emerin include nesprin-1alpha and transcriptional regulators such as germ cell-less (GCL). The binding affinities of these partners range from 4nM (nesprin-1alpha) to 200 nM (BAF), and are physiologically significant. Biochemical studies therefore provide a valid means to predict the properties of emerin-lamin complexes in vivo. Emerin and lamin A together form stable complexes with either BAF or GCL in vitro. BAF, however, competes with GCL for binding to emerin in vitro. These and additional partners, notably actin and nuclear myosin II, suggest disease-relevant roles for emerin in gene regulation and the mechanical interity of the nucleus.

    Topics: Actins; Animals; Gene Expression Regulation; Humans; Membrane Proteins; Muscular Dystrophies; Nuclear Envelope; Nuclear Proteins; Thymopoietins

2005
The nuclear muscular dystrophies.
    Seminars in pediatric neurology, 2002, Volume: 9, Issue:2

    Nuclear muscular dystrophies are referred to as inherited muscular dystrophies caused by mutations in genes--(STA) or lamina (LMNA)--encoding components of the nuclear envelope. Phenotypically, they present as Emery-Dreifuss muscular dystrophy (EDMD), limb-girdle muscle dystrophy 1B (LGMD1B), or dilated cardiomyopathy with conduction defects (DCM-CD). Genetically related are the Dunnigan-type of familial partial lipodystrophy (FPLD) and Charcot-Marie-Tooth neuropathy type 2 (CMT2B). Until now, approximately 70 unique STA mutations, leading to X-linked EDMD or DCM-CD, have resulted mostly in a complete lack of emerin. Further 50 mostly missense mutations in LMNA result in autosomal-dominant EDMD, autosomal-recessive EDMD, LGMD1B, DCM-CD, FPLD, or CMT2B. Independent of type or location of the mutations, emerinopathies and laminopathies show wide clinical intrafamilial and interfamilial variability. Although structural abnormalities of nuclei in animal and cell models have been observed, the molecular pathology of the nuclear muscular dystrophies needs still to be elucidated.

    Topics: Cardiomyopathy, Dilated; Chromosomes, Human, X; Gene Expression; Genotype; Humans; Membrane Proteins; Muscular Dystrophies; Neural Conduction; Nuclear Lamina; Nuclear Proteins; Phenotype; Point Mutation; Thymopoietins

2002
Emerin and cardiomyopathy in Emery-Dreifuss muscular dystrophy.
    Neuromuscular disorders : NMD, 1999, Volume: 9, Issue:2

    Emery-Dreifuss muscular dystrophy (EDMD) is an inherited disorder characterized by the clinical triad of life-threatening progressive cardiomyopathy with conduction defect, early onset joint contractures and slow progressive muscle weakness in scapulo-humero-peroneal distribution. Cardiomyopathy in EDMD is usually noticed after the second to third decade of life, and becomes worse with age. Permanent auricular paralysis occurs frequently and is considered a hallmark of EDMD cardiomyopathy. Cardiac involvement may also occur in female carriers. In autopsy cases, enlargement of the atria with remarkable thinning have been observed. Identification of the gene responsible for X-linked EDMD (X-EDMD) and the protein product, emerin, provided a diagnostic clue for EDMD. Since the emerin gene is rather small, the entire sequence can easily be surveyed. Western blot and immunohistochemistry show an absence of emerin in muscle and skin tissues and oral exfoliating cells in male patients with X-EDMD, and a reduction of the protein content with a mosaic expression pattern in female carriers. Emerin anchors at the inner nuclear membrane of cardiac, skeletal and smooth muscles, and interacts with lamins and nucleoplasm, thereby possibly maintaining the mechanical stability of the nuclear membrane of muscle cells that shows rigorous contraction/relaxation. More recently, positive emerin staining at the cardiac demosomes and fasciae adherentes was noticed in addition to the specific localization at the inner nuclear membrane. This localization implies a physiological role for the protein in cardiac conduction.

    Topics: Cardiomyopathies; Genetic Linkage; Humans; Membrane Proteins; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Nuclear Proteins; Thymopoietins; X Chromosome

1999
Emerin.
    The international journal of biochemistry & cell biology, 1999, Volume: 31, Issue:9

    Emerin encoded by the STA gene is the first nuclear protein linked with a muscular dystrophy. Emerin is a 34 kDa, predominantly hydrophilic protein with a single hydrophobic region supposed to serve as a transmembrane domain. It was classified as a type II integral membrane protein localized at the inner nuclear membrane/nuclear lamina with an ubiquitous tissue distribution. It is speculated that emerin is required for the stability and normal function of rigorously moving nuclei in skeletal muscle and heart. During mitosis, emerin is cell-cycle-dependent phosphorylated and shows stage-dependent changes in distribution and localization suggesting that it plays a role in re-assembly of nuclear membranes. Mutations of the emerin gene have been associated with X-linked Emery-Dreifuss muscular dystrophy clinically defined by early joint contractures, progressive muscle weakness, and cardiomyopathy. Hopefully, identification of the protein defect may promote new therapeutic strategies concerning muscle fiber development and stability.

    Topics: Animals; Humans; Membrane Proteins; Muscular Dystrophies; Nuclear Proteins; Thymopoietins

1999
Emery-Dreifuss syndrome.
    Current opinion in neurology, 1997, Volume: 10, Issue:5

    Emery-Dreifuss syndrome is a heterogeneous entity characterized by the following clinical triad: early contracture of the elbows. Achilles tendons and postcervical muscles; slowly progressive muscle wasting and weakness with a humeroperoneal distribution early in the course of disease; and a cardiomyopathy usually presenting as an atrioventricular block ranging from sinus bradycardia to complete heart block. As the heart block is the major problem, insertion of a cardiac pacemaker can be life saving. Recent advances through genetic and immunochemical studies have provided valuable clues to the understanding and the early diagnosis of this disease.

    Topics: Cardiomyopathies; Contracture; Diagnosis, Differential; Genes, Recessive; Heart Block; Humans; Membrane Proteins; Muscular Dystrophies; Nuclear Proteins; Sex Chromosome Aberrations; Thymopoietins; X Chromosome

1997
[Emery-Dreifuss muscular dystrophy].
    Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55, Issue:12

    Emery-Dreifuss muscular dystrophy (EDMD) is an inherited muscular disorder characterized by the triad of progressive weakness in humero-peroneal muscles, early onset contractures and cardiomyopathy with conduction block that shows a high risk of sudden death. In 1994, the gene responsible for X-linked EDMD has been identified to Xq28 (designated as STA), that encodes a serine-rich protein of 254 amino acids, named emerin. In 1996, we discovered a nuclear membrane localization of emerin in the normal skeletal, cardiac and smooth muscles, but not in the tissues from patients with X-linked EDMD who had a nonsense mutation in the gene. In conclusion, molecular and genetic analyses of emerin are essential for accurate diagnosis of patients with EDMD.

    Topics: Cardiomyopathies; Death, Sudden, Cardiac; Genes, Recessive; Humans; Membrane Proteins; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Mutation; Nuclear Proteins; Thymopoietins; X Chromosome

1997

Other Studies

50 other study(ies) available for emerin and Muscular-Dystrophies

ArticleYear
A novel mutation in human EMD gene and mitochondrial dysfunction in emerin knockdown cardiomyocytes.
    Journal of cellular and molecular medicine, 2022, Volume: 26, Issue:19

    Emerin is an inner nuclear envelope protein encoded by the EMD gene, mutations in which cause Emery-Dreifuss muscular dystrophy type 1 (EDMD1). Cardiac involvement has become a major threat to patients with EDMD1; however, the cardiovascular phenotype spectrums of emerinopathy and the mechanisms by which emerin regulates cardiac pathophysiology remain unclear. Here, we identified a novel nonsense mutation (c.C57G, p.Y19X) in the EMD gene in a Han Chinese family through high-throughput sequencing. Two family members were found to have EDMD1 with muscle weakness and cardiac arrhythmia. Mechanistically, we first discovered that knockdown of emerin in HL-1 or H9C2 cardiomyocytes lead to impaired mitochondrial oxidative phosphorylation capacity with downregulation of electron transport chain complex I and IV and upregulation of complex III and V. Moreover, loss of emerin in HL-1 cells resulted in collapsed mitochondrial membrane potential, altered mitochondrial networks and downregulated multiple factors in RNA and protein level, such as PGC1α, DRP1, MFF, MFN2, which are involved in regulation of mitochondrial biogenesis, fission and fusion. Our findings suggest that targeting mitochondrial bioenergetics might be an effective strategy against cardiac disorders caused by EMD mutations.

    Topics: Codon, Nonsense; Electron Transport Complex III; Humans; Membrane Proteins; Mitochondria; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Mutation; Myocytes, Cardiac; Nuclear Proteins; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; X-Linked Emery-Dreifuss Muscular Dystrophy

2022
Emerin Represses STAT3 Signaling through Nuclear Membrane-Based Spatial Control.
    International journal of molecular sciences, 2021, Jun-22, Volume: 22, Issue:13

    Topics: A549 Cells; Cell Nucleus; Cell Survival; Gene Expression Regulation; Humans; Janus Kinases; Membrane Proteins; Muscle, Skeletal; Muscular Dystrophies; Mutation; Nuclear Envelope; Nuclear Proteins; Protein Binding; Signal Transduction; STAT3 Transcription Factor; Transcription Factors

2021
Muscular Dystrophy Mutations Impair the Nuclear Envelope Emerin Self-assembly Properties.
    ACS chemical biology, 2015, Dec-18, Volume: 10, Issue:12

    More than 100 genetic mutations causing X-linked Emery-Dreifuss muscular dystrophy have been identified in the gene encoding the integral inner nuclear membrane protein emerin. Most mutations are nonsense or frameshift mutations that lead to the absence of emerin in cells. Only very few cases are due to missense or short in-frame deletions. Molecular mechanisms explaining the corresponding emerin variants' loss of function are particularly difficult to identify because of the mostly intrinsically disordered state of the emerin nucleoplasmic region. We now demonstrate that this EmN region can be produced as a disordered monomer, as revealed by nuclear magnetic resonance, but rapidly self-assembles in vitro. Increases in concentration and temperature favor the formation of long curvilinear filaments with diameters of approximately 10 nm, as observed by electron microscopy. Assembly of these filaments can be followed by fluorescence through Thioflavin-T binding and by Fourier-transform Infrared spectrometry through formation of β-structures. Analysis of the assembly properties of five EmN variants reveals that del95-99 and Q133H impact filament assembly capacities. In cells, these variants are located at the nuclear envelope, but the corresponding quantities of emerin-emerin and emerin-lamin proximities are decreased compared to wild-type protein. Furthermore, variant P183H favors EmN aggregation in vitro, and variant P183T provokes emerin accumulation in cytoplasmic foci in cells. Substitution of residue Pro183 might systematically favor oligomerization, leading to emerin aggregation and mislocalization in cells. Our results suggest that emerin self-assembly is necessary for its proper function and that a loss of either the protein itself or its ability to self-assemble causes muscular dystrophy.

    Topics: Genetic Variation; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; Magnetic Resonance Spectroscopy; Membrane Proteins; Muscular Dystrophies; Nuclear Envelope; Nuclear Proteins; Proteostasis Deficiencies; Spectroscopy, Fourier Transform Infrared

2015
Immunodetection analysis of muscular dystrophies in Mexico.
    Muscle & nerve, 2012, Volume: 45, Issue:3

    The muscular dystrophies (MDs) result from perturbations in the myofibers. These alterations are induced in part by mechanical stress due to membrane cell fragility, disturbances in mechanotransduction pathways, muscle cell physiology, and metabolism.. We analyzed 290 biopsies of patients with a clinical diagnosis of muscular dystrophy. Using immunofluorescence staining, we searched for primary and secondary deficiencies of 12 different proteins, including membrane, costamere, cytoskeletal, and nuclear proteins. In addition, we analyzed calpain-3 by immunoblot.. We identified 212 patients with varying degrees of protein deficiencies, including dystrophin, sarcoglycans, dysferlin, caveolin-3, calpain-3, emerin, and merosin. Moreover, 78 biopsies showed normal expression of all investigated muscle proteins. The frequency rates of protein deficiencies were as follows: 52.36% dystrophinopathies; 18.40% dysferlinopathies; 14.15% sarcoglycanopathies; 11.32% calpainopathies; 1.89% merosinopathies; 1.42% caveolinopathies; and 0.47% emerinopathies. Deficiencies in lamin A/C and telethonin were not detected.. We have described the frequency of common muscular dystrophies in Mexico.

    Topics: Adolescent; Adult; Calpain; Caveolin 3; Child; Child, Preschool; Creatine Kinase; Dysferlin; Dystrophin; Fluorescent Antibody Technique; Gene Expression Regulation; Humans; Infant; Laminin; Membrane Proteins; Mexico; Middle Aged; Muscle Proteins; Muscle, Skeletal; Muscular Dystrophies; Nuclear Proteins; Sarcoglycans; Severity of Illness Index; Young Adult

2012
The nuclear envelope protein emerin binds directly to histone deacetylase 3 (HDAC3) and activates HDAC3 activity.
    The Journal of biological chemistry, 2012, Jun-22, Volume: 287, Issue:26

    Organization of the genome is critical for maintaining cell-specific gene expression, ensuring proper cell function. It is well established that the nuclear lamina preferentially associates with repressed chromatin. However, the molecular mechanisms underlying repressive chromatin formation and maintenance at the nuclear lamina remain poorly understood. Here we show that emerin binds directly to HDAC3, the catalytic subunit of the nuclear co-repressor (NCoR) complex, and recruits HDAC3 to the nuclear periphery. Emerin binding stimulated the catalytic activity of HDAC3, and emerin-null cells exhibit increased H4K5 acetylation, which is the preferred target of the NCoR complex. Emerin-null cells exhibit an epigenetic signature similar to that seen in HDAC3-null cells. Emerin-null cells also had significantly less HDAC3 at the nuclear lamina. Collectively, these data support a model whereby emerin facilitates repressive chromatin formation at the nuclear periphery by increasing the catalytic activity of HDAC3.

    Topics: Animals; Catalysis; Cell Nucleus; Chromatin; Enzyme Activation; Epigenesis, Genetic; Genome; Histone Deacetylases; Histones; Kinetics; Membrane Proteins; Mice; Microscopy, Confocal; Muscular Dystrophies; Nuclear Envelope; Nuclear Proteins; Protein Binding; Subcellular Fractions

2012
Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration.
    Brain : a journal of neurology, 2006, Volume: 129, Issue:Pt 4

    Mutations of lamin A/C (LMNA) cause a wide range of human disorders, including progeria, lipodystrophy, neuropathies and autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD). EDMD is also caused by X-linked recessive loss-of-function mutations of emerin, another component of the inner nuclear lamina that directly interacts with LMNA. One model for disease pathogenesis of LMNA and emerin mutations is cell-specific perturbations of the mRNA transcriptome in terminally differentiated cells. To test this model, we studied 125 human muscle biopsies from 13 diagnostic groups (125 U133A, 125 U133B microarrays), including EDMD patients with LMNA and emerin mutations. A Visual and Statistical Data Analyzer (VISDA) algorithm was used to statistically model cluster hierarchy, resulting in a tree of phenotypic classifications. Validations of the diagnostic tree included permutations of U133A and U133B arrays, and use of two probe set algorithms (MAS5.0 and MBEI). This showed that the two nuclear envelope defects (EDMD LMNA, EDMD emerin) were highly related disorders and were also related to fascioscapulohumeral muscular dystrophy (FSHD). FSHD has recently been hypothesized to involve abnormal interactions of chromatin with the nuclear envelope. To identify disease-specific transcripts for EDMD, we applied a leave-one-out (LOO) cross-validation approach using LMNA patient muscle as a test data set, with reverse transcription-polymerase chain reaction (RT-PCR) validations in both LMNA and emerin patient muscle. A high proportion of top-ranked and validated transcripts were components of the same transcriptional regulatory pathway involving Rb1 and MyoD during muscle regeneration (CRI-1, CREBBP, Nap1L1, ECREBBP/p300), where each was specifically upregulated in EDMD. Using a muscle regeneration time series (27 time points) we develop a transcriptional model for downstream consequences of LMNA and emerin mutations. We propose that key interactions between the nuclear envelope and Rb and MyoD fail in EDMD at the point of myoblast exit from the cell cycle, leading to poorly coordinated phosphorylation and acetylation steps. Our data is consistent with mutations of nuclear lamina components leading to destabilization of the transcriptome in differentiated cells.

    Topics: Biopsy; Child; DNA Fingerprinting; Gene Expression Profiling; Humans; Lamin Type A; Membrane Proteins; Models, Statistical; Muscle, Skeletal; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Mutation; MyoD Protein; Nuclear Envelope; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Protein Binding; Regeneration; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thymopoietins; Transcription, Genetic

2006
Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation.
    Genes & development, 2006, Feb-15, Volume: 20, Issue:4

    Mutations within LMNA, encoding A-type nuclear lamins, are associated with multiple tissue-specific diseases, including Emery-Dreifuss (EDMD2/3) and Limb-Girdle muscular dystrophy (LGMD1B). X-linked EDMD results from mutations in emerin, a lamin A-associated protein. The mechanisms through which these mutations cause muscular dystrophy are not understood. Here we show that most, but not all, cultured muscle cells from lamin A/C knockout mice exhibit impaired differentiation kinetics and reduced differentiation potential. Similarly, normal muscle cells that have been RNA interference (RNAi) down-regulated for either A-type lamins or emerin have impaired differentiation potentials. Replicative myoblasts lacking A-type lamins or emerin also have decreased levels of proteins important for muscle differentiation including pRB, MyoD, desmin, and M-cadherin; up-regulated Myf5; but no changes in Pax3, Pax7, MEF2C, MEF2D, c-met, and beta-catenin. To determine whether impaired myogenesis is linked to reduced MyoD or desmin levels, these proteins were individually expressed in Lmna(-/-) myoblasts that were then induced to undergo myogenesis. Expression of either MyoD or, more surprisingly, desmin in Lmna(-/-) myoblasts resulted in increased differentiation potential. These studies indicate roles for A-type lamins and emerin in myogenic differentiation and also suggest that these effects are at least in part due to decreased endogenous levels of other critical myoblast proteins. The delayed differentiation kinetics and decreased differentiation potential of lamin A/C-deficient and emerin-deficient myoblasts may in part underlie the dystrophic phenotypes observed in patients with EDMD.

    Topics: Animals; Blotting, Western; Cell Differentiation; Desmin; Gene Expression Regulation; Immunohistochemistry; Lamin Type A; Membrane Proteins; Mice; Mice, Knockout; Muscular Dystrophies; Mutation; MyoD Protein; Nuclear Proteins; Oligonucleotides; Polymerase Chain Reaction; RNA Interference; Satellite Cells, Skeletal Muscle; Thymopoietins

2006
Implications for nuclear organization and gene transcription of lamin A/C specific mutations.
    Advances in enzyme regulation, 2005, Volume: 45

    Topics: Diabetes Mellitus, Lipoatrophic; Fibroblasts; Humans; Lamin Type A; Lamins; Membrane Proteins; Muscular Dystrophies; Mutation, Missense; Nuclear Lamina; Nuclear Proteins; Thymopoietins; Transcription, Genetic

2005
Pathological changes of the myonuclear fibrous lamina and internal nuclear membrane in two cases of autosomal dominant limb-girdle muscular dystrophy with atrioventricular conduction disturbance (LGMD1B).
    Acta neuropathologica, 2004, Volume: 107, Issue:2

    Mutations in the lamin A/C gene have been reported in a variety of disorders including autosomal dominant Emery-Dreifuss muscular dystrophy and autosomal dominant limb girdle muscular dystrophy with cardiac conduction block or limb girdle muscular dystrophy type 1B (LGMD1B). However, how these mutations are involved in developing these diseases is not known. We examined morphological changes of the skeletal muscle in two cases of LGMD1B in a family, directing our attention to the nuclear envelope and its underlying structures where lamin A/C is located. Although conventional fluorescence microscope revealed no discernible abnormality in the distribution of emerin and lamin A/C, a serial multi-layer scanning with confocal laser scanning microscope showed an attenuated and uneven distribution of lamin A/C. Furthermore, under an electron microscope, the nuclear fibrous lamina and inner nuclear membrane were relatively indistinct compared to controls. These changes in the myonuclei may be related to pathomechanisms of the present cases.

    Topics: Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Family Health; Female; Fluorescent Antibody Technique; Heart Diseases; Humans; Male; Membrane Proteins; Microscopy, Confocal; Microscopy, Electron; Middle Aged; Muscular Dystrophies; Nuclear Envelope; Nuclear Lamina; Nuclear Proteins; Skeletal Muscle Ventricle; Thymopoietins

2004
Emerin caps the pointed end of actin filaments: evidence for an actin cortical network at the nuclear inner membrane.
    PLoS biology, 2004, Volume: 2, Issue:9

    X-linked Emery-Dreifuss muscular dystrophy is caused by loss of emerin, a LEM-domain protein of the nuclear inner membrane. To better understand emerin function, we used affinity chromatography to purify emerin-binding proteins from nuclear extracts of HeLa cells. Complexes that included actin, alphaII-spectrin and additional proteins, bound specifically to emerin. Actin polymerization assays in the presence or absence of gelsolin or capping protein showed that emerin binds and stabilizes the pointed end of actin filaments, increasing the actin polymerization rate 4- to 12-fold. We propose that emerin contributes to the formation of an actin-based cortical network at the nuclear inner membrane, conceptually analogous to the actin cortical network at the plasma membrane. Thus, in addition to disrupting transcription factors that bind emerin, loss of emerin may destabilize nuclear envelope architecture by weakening a nuclear actin network.

    Topics: Actin Cytoskeleton; Actins; Binding Sites; Cell Membrane; Cell Nucleus; Chromatography, Affinity; Gelsolin; HeLa Cells; Humans; Membrane Proteins; Muscular Dystrophies; Nuclear Envelope; Nuclear Proteins; Protein Binding; Thymopoietins; Transcription, Genetic

2004
Nuclear envelope alterations in fibroblasts from patients with muscular dystrophy, cardiomyopathy, and partial lipodystrophy carrying lamin A/C gene mutations.
    Muscle & nerve, 2004, Volume: 30, Issue:4

    Mutations in LMNA, the gene that encodes nuclear lamins A and C, cause up to eight different diseases collectively referred to as "laminopathies." These diseases affect striated muscle, adipose tissue, peripheral nerve, and bone, or cause features of premature aging. We investigated the consequences of LMNA mutations on nuclear architecture in skin fibroblasts from 13 patients with different laminopathies. Western-blotting showed that none of the mutations examined led to a decrease in cellular levels of lamin A or C. Regardless of the disease, we observed honeycomb nuclear structures and nuclear envelope blebs in cells examined by immunofluorescence microscopy. Concentrated foci of lamin A/C in the nucleoplasm were also observed. Only mutations in the head and tail domains of lamins A and C significantly altered the nuclear architecture of patient fibroblasts. These results confirm that mutations in lamins A and C may lead to a weakening of a structural support network in the nuclear envelope in fibroblasts and that nuclear architecture changes depend upon the location of the mutation in different domains of lamin A/C.

    Topics: Adolescent; Adult; Blotting, Western; Cardiomyopathies; Cell Count; Cell Nucleus; Child; Female; Fibroblasts; Humans; Lamin Type A; Lipodystrophy; Male; Membrane Proteins; Microscopy, Fluorescence; Middle Aged; Muscular Dystrophies; Mutation; Nuclear Envelope; Nuclear Proteins; Phenotype; Thymopoietins

2004
Nuclear envelope alterations in fibroblasts from LGMD1B patients carrying nonsense Y259X heterozygous or homozygous mutation in lamin A/C gene.
    Experimental cell research, 2003, Dec-10, Volume: 291, Issue:2

    Mutations in the LMNA gene encoding nuclear lamins A and C are responsible for seven inherited disorders affecting specific tissues. We have analyzed skin fibroblasts from a patient with type 1B limb-girdle muscular dystrophy and from her deceased newborn grandchild carrying, respectively, a heterozygous (+/mut) and a homozygous (mut/mut) nonsense Y259X mutation. In fibroblasts(+/mut), the presence of only 50% lamins A and C promotes no detectable abnormality, whereas in fibroblasts(mut/mut) the complete absence of lamins A and C leads to abnormally shaped nuclei with lobules in which none of the analyzed nuclear proteins were detected, i.e., B-type lamins, emerin, nesprin-1alpha, LAP2beta, and Nup153. These lobules perturb cell division as fibroblast(mut/mut) cultures with large proportions of cells with dysmorphic nuclei grow more slowly than controls and the cell proliferation normalizes when the number of these abnormally shaped nuclei declines. In all fibroblasts(mut/mut), nesprin-1alpha-like emerin exhibited aberrant localization in the endoplasmic reticulum. Transfection of wild-type lamin A or C cDNAs restored the correct localization of both emerin and nesprin-1alpha. These data demonstrate that lamin C, like lamin A, interacts in vivo directly with nesprin-1alpha and with emerin and that lamin A or C is sufficient for the correct anchorage of emerin and nesprin-1alpha at the nuclear envelope in human cells.

    Topics: Carrier Proteins; Cell Division; Codon, Nonsense; Cytoskeletal Proteins; Endoplasmic Reticulum; Family Health; Female; Fibroblasts; Heterozygote; Homozygote; Humans; Infant, Newborn; Lamin Type A; Male; Membrane Proteins; Muscular Dystrophies; Nerve Tissue Proteins; Nuclear Envelope; Nuclear Proteins; RNA-Binding Proteins; Thymopoietins

2003
Mutation analysis of the lamin A/C gene (LMNA) among patients with different cardiomuscular phenotypes.
    Journal of medical genetics, 2003, Volume: 40, Issue:12

    Topics: Adolescent; Adult; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Child; DNA Mutational Analysis; Heart Diseases; Humans; Lamin Type A; Lamins; Membrane Proteins; Middle Aged; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Mutation; Nuclear Proteins; Phenotype; Thymopoietins

2003
The R482Q lamin A/C mutation that causes lipodystrophy does not prevent nuclear targeting of lamin A in adipocytes or its interaction with emerin.
    European journal of human genetics : EJHG, 2001, Volume: 9, Issue:3

    Most pathogenic missense mutations in the lamin A/C gene identified so far cause autosomal-dominant dilated cardiomyopathy and/or Emery-Dreifuss muscular dystrophy. A few specific mutations, however, cause a disease with remarkably different clinical features: FPLD, or familial partial lipodystrophy (Dunnigan-type), which mainly affects adipose tissue. We have prepared lamin A with a known FPLD mutation (R482Q) by in vitro mutagenesis. Nuclear targeting of lamin A in transfected COS cells, human skeletal muscle cells or mouse adipocyte cell cultures (pre- and post-differentiation) was not detectably affected by the mutation. Quantitative in vitro measurements of lamin A interaction with emerin using a biosensor also showed no effect of the mutation. The results show that the loss of function of R482 in lamin A/C in FPLD does not involve loss of ability to form a nuclear lamina or to interact with the nuclear membrane protein, emerin.

    Topics: Adipocytes; Animals; Base Sequence; Cardiomyopathy, Dilated; Cell Nucleus; COS Cells; DNA Primers; Lamin Type A; Lamins; Lipodystrophy; Membrane Proteins; Muscular Dystrophies; Mutation; Nuclear Proteins; Thymopoietins

2001
Distribution of emerin and lamins in the heart and implications for Emery-Dreifuss muscular dystrophy.
    Human molecular genetics, 1999, Volume: 8, Issue:2

    Emerin is a nuclear membrane protein which is missing or defective in Emery-Dreifuss muscular dystrophy (EDMD). It is one member of a family of lamina-associated proteins which includes LAP1, LAP2 and lamin B receptor (LBR). A panel of 16 monoclonal antibodies (mAbs) has been mapped to six specific sites throughout the emerin molecule using phage-displayed peptide libraries and has been used to localize emerin in human and rabbit heart. Several mAbs against different emerin epitopes did not recognize intercalated discs in the heart, though they recognized cardiomyocyte nuclei strongly, both at the rim and in intranuclear spots or channels. A polyclonal rabbit antiserum against emerin did recognize both nuclear membrane and intercalated discs but, after affinity purification against a pure-emerin band on a western blot, it stained only the nuclear membrane. These results would not be expected if immunostaining at intercalated discs were due to a product of the emerin gene and, therefore, cast some doubt upon the hypothesis that cardiac defects in EDMD are caused by absence of emerin from intercalated discs. Although emerin was abundant in the membranes of cardiomyocyte nuclei, it was absent from many non-myocyte cells in the heart. This distribution of emerin was similar to that of lamin A, a candidate gene for an autosomal form of EDMD. In contrast, lamin B1 was absent from cardiomyocyte nuclei, showing that lamin B1 is not essential for localization of emerin to the nuclear lamina. Lamin B1 is also almost completely absent from skeletal muscle nuclei. In EDMD, the additional absence of lamin B1 from heart and skeletal muscle nuclei which already lack emerin may offer an alternative explanation of why these tissues are particularly affected.

    Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Humans; Immunohistochemistry; Lamin Type A; Lamin Type B; Lamins; Membrane Proteins; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Molecular Sequence Data; Muscular Dystrophies; Myocardium; Nuclear Proteins; Rabbits; Rats; Sequence Homology, Amino Acid; Thymopoietins

1999
Distinct regions specify the nuclear membrane targeting of emerin, the responsible protein for Emery-Dreifuss muscular dystrophy.
    European journal of biochemistry, 1999, Volume: 259, Issue:3

    Emery-Dreifuss muscular dystrophy is a neuromuscular disorder that has three characteristics: (a) early contracture of the elbows, Achilles tendons and postcervical muscles; (b) slowly progressive wasting and weakness of skeletal muscle; and (c) cardiomyopathy with severe conduction block. The responsible gene for the X-linked recessive form of this disease encodes an inner nuclear membrane protein named emerin. Although emerin is absent in tissues from patients with this disorder, it remains obscure why the loss of this widely expressed protein affects selectively skeletal muscle, heart and joints. As the first step to address this question, we examined the molecular regions of emerin that are essential for nuclear membrane targeting and stability of the protein. We found that the C-terminal hydrophobic region was necessary, but not sufficient, for nuclear membrane anchoring and stability of the protein. In the absence of this transmembrane domain, the upstream nucleoplasmic domain showed no firm association with the nuclear rim, but showed the tendency to accumulate at the nucleolus-like structures. Furthermore, proper targeting of emerin to the nuclear membrane required the latter half of the nucleoplasmic domain. These characteristics are distinct from those of lamina-associated polypeptide 2. Our findings indicate that emerin has distinct interactions with the inner nuclear membrane components that may be required for the stability and function of rigorously moving nuclei in tissues such as skeletal muscle, heart and joints.

    Topics: Cell Line; DNA-Binding Proteins; Fluorescent Antibody Technique; Green Fluorescent Proteins; Humans; Luminescent Proteins; Membrane Proteins; Microscopy, Immunoelectron; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Mutation; Nuclear Envelope; Nuclear Proteins; Proto-Oncogene Proteins c-myc; Recombinant Fusion Proteins; Thymopoietins

1999
Intracellular trafficking of emerin, the Emery-Dreifuss muscular dystrophy protein.
    Journal of cell science, 1999, Volume: 112 ( Pt 11)

    Emerin is an integral protein of the inner nuclear membrane that is mutated or not expressed in patients with Emery-Dreifuss muscular dystrophy. Confocal immunofluorescence microscopy studies of the intracellular targeting of truncated forms of emerin, some of which are found in patients with Emery-Dreifuss muscular dystrophy, show that the nucleoplasmic, amino-terminal domain is necessary and sufficient for nuclear retention. When this domain is fused to a transmembrane segment of an integral membrane protein of the ER/plasma membrane, the chimeric protein is localized in the inner nuclear membrane. The transmembrane segment of emerin is not targeted to the inner nuclear membrane. Fluorescence photobleaching experiments of emerin fused to green fluorescent protein demonstrate that the diffusional mobility (D) of emerin is decreased in the inner nuclear membrane (D=0.10+/-0.01 microm2/second) compared to the ER membrane (D=0.32+/-0.01 microm2/second). This is in agreement with a model where integral proteins reach the inner nuclear membrane by lateral diffusion and are retained there by association with nucleoplasmic components. Some overexpressed emerin-green fluorescent protein also reaches the plasma membrane of transfected cells, where its diffusion is similar to that in the inner nuclear membrane, suggesting that emerin may also associate with non-nuclear structures.

    Topics: Animals; Binding Sites; Biological Transport; Cell Membrane; Cell Nucleus; Chickens; COS Cells; Endoplasmic Reticulum; Humans; Intracellular Fluid; Membrane Proteins; Muscular Dystrophies; Mutagenesis; Nuclear Envelope; Nuclear Proteins; Recombinant Fusion Proteins; Thymopoietins

1999
Changes at P183 of emerin weaken its protein-protein interactions resulting in X-linked Emery-Dreifuss muscular dystrophy.
    Human genetics, 1999, Volume: 104, Issue:3

    Emery-Dreifuss muscular dystrophy (EDMD) is an X-linked recessive muscular dystrophy characterized by early contractures of the elbows, Achilles tendons and spine, slowly progressive muscle wasting and weakness, and cardiomyopathy associated with cardiac conduction defects. The emerin gene has been mapped to Xq28 and encodes a 34-kDa serine-rich protein, emerin, which has been localized to the nuclear envelope in a wide variety of tissues, including skeletal and cardiac muscle. Mutations spanning the emerin gene have been identified in patients with EDMD. We present here the effect, on emerin protein expression, of two missense mutations identified in unrelated EDMD patients. These alterations predict the replacement of a proline residue at position 183 with either a histidine or a threonine. Biochemical analysis has demonstrated that the mobility and expression levels of the mutant forms of emerin are indistinguishable from that of wild-type emerin, but that they have weakened interactions with nuclear lamina components. In comparison with the usual EDMD phenotype, patients with P183 missense mutations have a later age at onset of first symptoms, elbow contractures, ankle contractures, upper limb weakness and lower limb weakness, but there is no difference for the age at onset of cardiac involvement. This is the first report of protein studies on patients with missense mutations resulting in the clinical features of EDMD. These studies demonstrate the importance of proline 183 for the proper structure/function of emerin.

    Topics: Adult; Amino Acid Substitution; Cell Line, Transformed; DNA Mutational Analysis; Genetic Linkage; Genotype; Humans; Immunoblotting; Male; Membrane Proteins; Membranes; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Mutation; Nuclear Proteins; Phenotype; Phosphorylation; Proline; Protein Binding; Thymopoietins; X Chromosome

1999
Cardiac involvement in Emery Dreifuss muscular dystrophy: a case series.
    Heart (British Cardiac Society), 1999, Volume: 82, Issue:1

    Three patients with Emery Dreifuss muscular dystrophy are reported. Emery Dreifuss muscular dystrophy is an X linked muscular dystrophy, in which locomotor involvement is characteristically mild and slowly progressive. The effect on the heart becomes apparent in the teenage years and is characterised by cardiac conduction defects and infiltration of the myocardium by fibrous and adipose tissue. It first affects the atria, which results in atrial paralysis; treatment with ventricular pacing is usually needed. Female carriers can develop heart problems and are at risk of sudden death. Relatives of affected patients should be offered screening with electrocardiography and echocardiography.

    Topics: Adult; Echocardiography; Electrocardiography; Female; Genetic Linkage; Heart Atria; Heart Block; Humans; Male; Membrane Proteins; Middle Aged; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Nuclear Proteins; Paralysis; Thymopoietins; X Chromosome

1999
Genotype-phenotype analysis in X-linked Emery-Dreifuss muscular dystrophy and identification of a missense mutation associated with a milder phenotype.
    Neuromuscular disorders : NMD, 1999, Volume: 9, Issue:3

    Direct sequencing of the emerin gene in 22 families with Emery-Dreifuss muscular dystrophy (EMD) revealed mutations in 21 (95%), confirming that emerin mutations can be identified in the majority of families with X-linked EMD. Most emerin mutations result in absence of the protein. In this study three mutations (a missense mutation Pro183Thr and two in-frame deletions removing residues 95-99 and 236-241, respectively) were unusual in being associated with expression of mutant protein. The phenotype in these families was compared in detail with the clinical features in cases with typical null mutations. For the in-frame deletions there were no significant differences. In the family with the missense mutation the phenotype was milder. Age at onset was later for first symptoms and for development of ankle contractures and muscle weakness. These findings have diagnostic implications as well as pointing to functionally important regions of the emerin protein.

    Topics: Amino Acid Substitution; DNA; DNA Mutational Analysis; Family Health; Female; Genetic Linkage; Genotype; Humans; Male; Membrane Proteins; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Mutation, Missense; Nuclear Proteins; Pedigree; Phenotype; Proline; Threonine; Thymopoietins; X Chromosome

1999
Severe clinical expression in X-linked Emery-Dreifuss muscular dystrophy.
    Neuromuscular disorders : NMD, 1999, Volume: 9, Issue:3

    X-linked Emery-Dreifuss muscular dystrophy (EDMD) is a relatively rare benign neuromuscular disorder which can vary remarkably in onset, course and severity. In the present study, a TCTAC deletion spanning the nucleotides 631-635 of the emerin gene caused an unusually severe disease phenotype including loss of ambulation and severe muscle wasting in two affected brothers. The same mutation has been reported previously in an unrelated family showing a significantly milder phenotype. The interfamilial heterogeneity in distribution and in severity of the features in the two families point to environmental or genetic modification as the cause of clinical variability in Emery-Dreifuss muscular dystrophy.

    Topics: Adolescent; Adult; Base Sequence; Child; Child, Preschool; DNA; DNA Mutational Analysis; Family Health; Female; Gene Expression; Genetic Linkage; Humans; Infant; Male; Membrane Proteins; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Nuclear Proteins; Pedigree; Phenotype; Sequence Deletion; Thymopoietins; X Chromosome

1999
The Emery-Dreifuss Muscular Dystrophy Mutation Database.
    Neuromuscular disorders : NMD, 1999, Volume: 9, Issue:3

    Topics: Databases, Factual; Genetic Linkage; Humans; Membrane Proteins; Muscular Dystrophies; Mutation; Nuclear Proteins; Thymopoietins; X Chromosome

1999
The Emery-Dreifuss muscular dystrophy phenotype arises from aberrant targeting and binding of emerin at the inner nuclear membrane.
    Journal of cell science, 1999, Volume: 112 ( Pt 15)

    The product of the X-linked Emery-Dreifuss muscular dystrophy gene is a single-membrane-spanning protein called emerin, which is localized to the inner nuclear membrane of all tissues studied. To examine whether a number of the mutant forms of emerin expressed in patients are mislocalized, we transfected GFP-emerin cDNA constructs reflecting these mutations into undifferentiated C2C12 myoblasts and showed that both wild type and all the mutant emerins are targeted to the nuclear membrane, but the mutants to a lesser extent. Mutant Del236-241 (deletion in transmembrane region) was mainly expressed as cytoplasmic aggregates, with only trace amounts at the nuclear envelope. Complete removal of the transmembrane region and C-terminal tail relocated emerin to the nucleoplasm. Mutations in emerin's N-terminal domain had a less severe effect on disrupting nuclear envelope targeting. This data suggests that emerin contains multiple non-overlapping nuclear-membrane-targeting determinants. Analysis of material immunoisolated using emerin antibodies, from either undifferentiated C2C12 myoblasts or purified hepatocyte nuclei, demonstrated that both A- and B-type lamins and nuclear actin interact with emerin. This is the first report of proteins interacting with emerin. The EDMD phenotype can thus arise by either the absence or a reduction in emerin at the nuclear envelope, and both of these disrupt its interactions with that of structural components of the nucleus. We propose that an emerin-nuclear protein complex exists at the nuclear envelope and that one of its primary roles is to stabilize the nuclear membrane against the mechanical stresses that are generated in muscle cells during contraction.

    Topics: Amino Acid Substitution; Animals; Base Sequence; Cell Line; COS Cells; Green Fluorescent Proteins; Humans; Luminescent Proteins; Membrane Proteins; Mice; Molecular Sequence Data; Muscle, Skeletal; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Mutation, Missense; Nuclear Envelope; Nuclear Proteins; Phenotype; Polymerase Chain Reaction; Recombinant Fusion Proteins; Sequence Deletion; Thymopoietins; Transfection; X Chromosome

1999
A protein truncation test for Emery-Dreifuss muscular dystrophy (EMD): detection of N-terminal truncating mutations.
    Neuromuscular disorders : NMD, 1999, Volume: 9, Issue:4

    X-linked Emery-Dreifuss muscular dystrophy (EMD) is caused by mutations in the emerin gene. Since the emerin gene is ubiquitously expressed and since all EMD mutations published so far should be detectable by an RNA-based mutation assay, we have designed a protein truncation test for emerin. To facilitate the detection of mutations in the translation initiation site, reported for several EMD-cases, the standard tailed forward PTT-primer had to be modified. The effectiveness of the assay was established by a mutation scan in four EMD-patients. Two patients could be shown to carry emerin mutations, one affecting the ATG translation initiation codon. The PTT-assay did not detect a mutation in the two other patients. Since an immunohistochemical analysis of patient-derived cells revealed normal emerin levels, these patients are thus affected by another muscular dystrophy, most likely autosomal dominant EMD.

    Topics: Codon; DNA; Genetic Linkage; Humans; Immunohistochemistry; Membrane Proteins; Muscle Proteins; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Mutation; Nuclear Proteins; Protein Biosynthesis; Reverse Transcriptase Polymerase Chain Reaction; RNA; Thymopoietins; Transcription, Genetic; X Chromosome

1999
Mutation analysis in Emery-Dreifuss muscular dystrophy.
    Pediatric neurology, 1999, Volume: 21, Issue:1

    The purpose of this study was to search for STA gene defects in three families with clinically typical Emery-Dreifuss muscular dystrophy. Emery-Dreifuss is an X-linked muscular dystrophy with humeroperoneal weakness and life-threatening, but treatable, cardiac abnormalities in male patients and in female carriers. The defect is in the gene coding for emerin, a 254 amino acid protein of unknown function. Complementary and genomic DNA from T lymphocytes from the reported patients and their family members were amplified, cloned, and sequenced. A novel mutation, a 26 base-pair deletion in three brothers and a carrier mother, was detected in one family. A splicing mutation with one base pair insertion and a five base-pair deletion, which have been described previously, were found in the second and third families, respectively. The additional novel mutation detected and the findings of three different mutations in these three families support the idea of genetic heterogeneity of Emery-Dreifuss muscular dystrophy with different mutations in different families.

    Topics: Adolescent; Adult; Child; Consanguinity; DNA Mutational Analysis; Genetic Linkage; Heart Diseases; Humans; Male; Membrane Proteins; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Nuclear Proteins; Sequence Deletion; Thymopoietins; X Chromosome

1999
Distribution of emerin during the cell cycle.
    European journal of cell biology, 1999, Volume: 78, Issue:10

    Human emerin is a nuclear membrane protein that is lost or altered in patients with Emery-Dreifuss muscular dystrophy (EMD). While the protein is expressed in the majority of human tissues analyzed, the pathology predominates in cardiac and skeletal muscles of patients with EMD. Our results show that emerin can be detected by immunocytochemistry and immunoblotting in the nuclear envelope of all vertebrates studied from man to Xenopus. Immunolocalizations and nuclear envelope extraction experiments confirm that emerin possesses properties characteristic for integral membrane proteins of the inner nuclear membrane. Some nuclear envelope proteins are localized also in annulate lamellae (AL), i.e. cytoplasmic flattened membrane cisternae penetrated by pore complexes. To verify whether emerin is contained in these membrane stacks, we have induced the formation of AL by exposure of rat cells (line RV-SMC) to sublethal doses of the antimitotic drug vinblastine sulfate and found that emerin is present in the nuclear envelope, but is absent from AL. In contrast to the homogeneous distribution of emerin in the nuclear envelope of interphase cells, this protein shows a focal accumulation in the nuclear membranes of late telophase cells. During early reassembly of the nuclear envelope at this mitotic stage emerin colocalizes with lamin A/C but not with lamin B and LAP2 proteins. Confocal laser scanning microscopy after double-labeling experiments with emerin and tubulin shows that emerin is concentrated in areas of the mitotic spindle and in the midbody of mitotic cells suggesting a close interaction of these proteins. Our data suggest that emerin participates in the reorganisation of the nuclear envelope at the end of mitosis.

    Topics: Animals; Biological Evolution; Cell Cycle; Cell Line; Cricetinae; Humans; Macropodidae; Membrane Proteins; Mice; Microscopy, Fluorescence; Mitosis; Muscular Dystrophies; Nuclear Envelope; Nuclear Proteins; Rats; Thymopoietins; Xenopus laevis

1999
Emerin deletions occurring on both Xq28 inversion backgrounds.
    Human molecular genetics, 1998, Volume: 7, Issue:1

    Emery-Dreifuss muscular dystrophy (EMD) is an X-linked disorder characterized by contractures, progressive weakness and cardiomyopathy. EMD is caused by mutations in the 2 kb emerin gene that is located within human Xq28. Emerin is immediately distal to the 26 kb filamin gene, and flanking the filamin-emerin region are two large inverted repeats. This entire region previously has been found to be inverted in approximately 20% of X chromosomes, presumably mediated by the inverted repeats. Only one complete emerin deletion has been reported previously. It was found to be due to a complex rearrangement involving the inverted repeats which partially duplicated filamin. We report here two additional EMD patients who have large deletions of 20 and 34 kb, respectively. Unlike the previously reported deletion, these deletions appear to be simple deletions, with each breakpoint junction showing only 2 bp of overlap, suggesting an end-joining mechanism. However, the two deletions were found on each of the two inverted backgrounds. The 20 kb deletion includes the entire emerin gene and extends well into most of the distal inverted repeat. In contrast, the 34 kb deletion occurs on the inverted X chromosome and extends centromeric, well beyond the proximal inverted repeat. In addition, at least three nearby putative genes detected by previous sequence analysis are deleted among these patients but without obvious deviation from a typical EMD phenotype. Similarly to the previously reported deletion, filamin remains intact in these two deletions. All three deletions involve distinct breakpoints within the 4.7 kb filamin-emerin intergenic region, suggesting that loss of filamin is a lethal event. Thus, the close proximity of filamin to emerin may place constraints upon potential emerin deletions and probably accounts for the rarity of complete emerin deletions in EMD patients.

    Topics: Chromosome Inversion; Gene Deletion; Humans; Membrane Proteins; Muscular Dystrophies; Nuclear Proteins; Thymopoietins; X Chromosome

1998
Aberrant intracellular targeting and cell cycle-dependent phosphorylation of emerin contribute to the Emery-Dreifuss muscular dystrophy phenotype.
    Journal of cell science, 1998, Volume: 111 ( Pt 6)

    The product of the X-linked Emery-Dreifuss muscular dystrophy gene is a protein called emerin, which is localized to the nuclear membrane. We have expressed full-length recombinant human emerin in an in vitro coupled reticulocyte system; it has a molecular mass of 34 kDa, inserts into microsomes in a type II orientation, and does not exhibit any N-linked glycosylation or cleavage event. Affinity-purified human emerin antiserum cross-reacts with the in vitro-expressed emerin and with a 34 kDa band present in a wide range of human tissue samples. Expression and subcellular distribution of emerin were studied in lymphoblastoid cell lines established from four patients with Emery-Dreifuss muscular dystrophy containing different mutations in the emerin gene. Emerin protein was detected in two of these patients by immunoblotting. In striking contrast to wild-type emerin, which was localized to the nuclear fraction and was insoluble in non-ionic detergents and high salt, emerin from these two patients exhibited a more random subcellular localization and increased solubility. On the basis of the mutations present in these patients, it would appear that emerin possesses two non-overlapping nuclear envelope targeting sequences. We have also demonstrated that emerin can occur in four different phosphorylated forms, three of which appear to be associated with the cell cycle. The mutant forms of emerin taken from the two patients exhibited aberrant cell cycle-dependent phosphorylated forms. This data suggests that for emerin to function normally it must be correctly localized, retained at the nuclear membrane and phosphorylated by cell cycle-mediated events.

    Topics: Adult; Alkaline Phosphatase; Amino Acid Sequence; Animals; Cell Cycle; Cell Line, Transformed; Cloning, Molecular; DNA, Complementary; Humans; Immune Sera; Intracellular Fluid; Male; Membrane Proteins; Molecular Sequence Data; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Nuclear Proteins; Octoxynol; Phenotype; Phosphorylation; Rats; Recombinant Proteins; Sodium Chloride; Solubility; Subcellular Fractions; Thymopoietins

1998
Mutations in Emery-Dreifuss muscular dystrophy and their effects on emerin protein expression.
    Human molecular genetics, 1998, Volume: 7, Issue:5

    Seventeen families with Emery-Dreifuss muscular dystrophy (EDMD) have been studied both by DNA sequencing and by emerin protein expression. Fourteen had mutations in the X-linked emerin gene, while three showed evidence of autosomal inheritance. Twelve of the 14 emerin mutations caused early termination of translation. An in-frame deletion of six amino acids from the C-terminal transmembrane helix caused almost complete absence of emerin from muscle with no localization to the nuclear membrane, although mRNA levels were normal. This shows that mutant emerin proteins are unstable if they are unable to integrate into a membrane. A 22 bp deletion in the promoter region was expected to result in reduced emerin production, but normal amounts of emerin of normal size were found in leucocytes and lymphoblastoid cell lines. This shows that DNA analysis is necessary to exclude emerin mutations in suspected X-linked EDMD. Emerin levels in female carriers often deviated from the expected 50% and this was due, in at least two families, to skewed emerin mRNA expression from the normal and mutated alleles. In one family with a novel deletion of the last three exons of the emerin gene, a carrier had a cardiomyopathy and very low emerin levels (<5% of normal) due to skewed X-inactivation. In the three autosomal cases of EDMD, emerin was normal on western blots of blood cells, which suggests that autosomal EDMD is not caused by indirect reduction of emerin levels.

    Topics: Adolescent; Adult; Cell Line, Transformed; Child; DNA Mutational Analysis; Female; Humans; Lymphocytes; Male; Membrane Proteins; Middle Aged; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Mutation; Nuclear Proteins; Pedigree; Thymopoietins; X Chromosome

1998
Early presentation of X-linked Emery-Dreifuss muscular dystrophy resembling limb-girdle muscular dystrophy.
    Neuromuscular disorders : NMD, 1998, Volume: 8, Issue:2

    Emery-Dreifuss muscular dystrophy is an X-linked neuromuscular disorder caused by defects in the STA gene on Xq28, which codes for a nuclear protein named emerin. Affected patients usually present in early adolescence with scapulo-peroneal muscle weakness and wasting, and contractures of the tendo Achilles, elbows and paraspinal muscles, resulting in spine rigidity. We present here a case of Emery-Dreifuss muscular dystrophy with an unusually severe, early presentation. He presented at 2.5 years with predominantly proximal weakness and mild equinovarus deformity of the right foot. Serum creatine kinase activity was elevated (1994 IU/I) and a muscle biopsy at the age of 4 years showed marked dystrophic abnormalities. Normal expression of dystrophin, and no detectable deletion in the corresponding gene, excluded a diagnosis of Duchenne muscular dystrophy. Similarly, normal expression of alpha-sarcoglycan made a limb-girdle muscular dystrophy caused by a defect in a sarcoglycan unlikely. Several years later, examination of the proband's maternal cousin, aged 14 years, suggested Emery-Dreifuss muscular dystrophy. This was confirmed in both affected boys by the absence of emerin in muscle and leucocytes, and identification of a mutation in exon 4 of the STA gene. Carrier status in both mothers was also confirmed by mutational and protein analysis. Emery-Dreifuss muscular dystrophy should therefore be considered in the differential diagnosis of cases of early onset muscular dystrophy, even in the absence of the typical clinical features.

    Topics: Age of Onset; Biopsy; Child, Preschool; Diagnosis, Differential; Genetic Linkage; Humans; Leukocytes; Male; Membrane Proteins; Muscles; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Mutation; Nuclear Proteins; Pedigree; Skin; Thymopoietins; X Chromosome

1998
Immunocytochemical detection of emerin within the nuclear matrix.
    Neuromuscular disorders : NMD, 1998, Volume: 8, Issue:5

    Emerin, the protein whose production is altered in the X-linked form of Emery-Dreifuss muscular distrophy, has been hypothesized to be associated with the nuclear matrix on the basis of biochemical studies. In addition, immunocytochemical data reported its localization at the nuclear periphery, on the nuclear lamina, in sections of several normal tissues. We investigated the association of emerin with the nuclear matrix, by using cultured cells (SaOS-2, MG63 and HeLa-S3) and their in situ extracted matrix as a model, and immunocytochemical methods, both at the light and electron microscope level. Our results show a normal presence of emerin in the cultured cells and the specific persistence of emerin on the lamina of the in situ extracted nuclear matrix. This suggests a tight binding between emerin and the nuclear lamina independently from the interactions between the C-terminal hydrophobic domain of the protein and the inner nuclear membrane.

    Topics: Cell Nucleus; Cells, Cultured; Fluorescent Antibody Technique, Direct; HeLa Cells; Humans; Immunohistochemistry; Membrane Proteins; Microscopy, Electron; Muscular Dystrophies; Nuclear Proteins; Thymopoietins

1998
Colocalization of emerin and lamins in interphase nuclei and changes during mitosis.
    Biochemical and biophysical research communications, 1998, Aug-28, Volume: 249, Issue:3

    Emerin is a nuclear membrane protein which is affected by mutation in X-linked Emery-Dreifuss muscular dystrophy. We have previously suggested that emerin is a member of a family of type II integral membrane proteins which associate with the nuclear lamina and which include lamina-associated proteins and the lamin B receptor. We now show that emerin in COS cells is not restricted to the nuclear rim but is also found at intranuclear sites, where it colocalizes with nuclear lamins B1, B2 and A/C. During mitosis, emerin is dispersed throughout the cell and then participates in the reconstitution of membranes around the daughter nuclei. Although emerin and lamins do not remain colocalized during mitosis, they all show some association with the midbody of the mitotic spindle.

    Topics: Animals; Antibodies, Monoclonal; Cell Nucleus; Chlorocebus aethiops; COS Cells; DNA-Binding Proteins; Fluorescent Antibody Technique; Humans; Interphase; Lamin Type B; Lamins; Membrane Proteins; Mitosis; Muscular Dystrophies; Nuclear Proteins; Spindle Apparatus; Thymopoietins

1998
Early onset, autosomal recessive muscular dystrophy with Emery-Dreifuss phenotype and normal emerin expression.
    Neurology, 1998, Volume: 51, Issue:4

    To describe the clinical and histopathologic picture of a childhood-onset, severe variant of scapuloperoneal MD with rigidity of the spine.. Rigidity of the spine is a feature of numerous syndromes, including X-linked Emery-Dreifuss MD, Bethlem myopathy, and the rigid spine syndrome. These are, however, relatively static or very slowly progressive neuromuscular disorders, usually associated with preserved ambulation into adult life.. Five unrelated children (three boys and two girls) presented in the first 2 years of life with poor neck control, waddling gait, and frequent falls. Early wasting of the distal leg muscles, biceps, triceps, and neck muscles was noted in all patients, and all had contractures and severe rigidity of the spine. The condition progressed rapidly, and all patients lost ambulation before the age of 8 years. Cardiac function was normal in all.. Creatine kinase was moderately elevated in all, and muscle biopsy specimens showed nonspecific dystrophic changes with normal expression of dystrophin, the sarcoglycans, and laminin alpha2, alpha5, beta1, and gamma1 chains. Emerin expression was normal in two of the boys whose tissue was available for study.. The distribution of weakness, wasting, and contractures of the patients described resembled Emery-Dreifuss MD, but the rapid progression of weakness and contractures and the involvement of both sexes together with normal emerin expression suggest that this form is not X-linked Emery-Dreifuss MD. We suggest that these patients represent a severe MD characterized by early onset distal wasting and severe rigidity of the spine, with probable autosomal recessive inheritance.

    Topics: Age of Onset; Biopsy; Child, Preschool; Contracture; Female; Genes, Recessive; Humans; Infant; Male; Membrane Proteins; Muscle Weakness; Muscle, Skeletal; Muscular Dystrophies; Nuclear Proteins; Phenotype; Thymopoietins; X Chromosome

1998
A Japanese family carrying a novel mutation in the Emery-Dreifuss muscular dystrophy gene.
    Annals of neurology, 1997, Volume: 41, Issue:3

    We report on a Japanese family affected by Emery-Dreifuss muscular dystrophy carrying a novel mutation of the emerin (STA) gene. The cardinal clinical feature of the family was cardiac conduction block and mild myopathy. A deletion of 11 bp with a frameshift was identified in exon 6, causing truncation of the predicted protein. The relationship between mutation and phenotype is discussed.

    Topics: Adolescent; Adult; Amino Acid Sequence; Female; Frameshift Mutation; Humans; Male; Membrane Proteins; Muscular Dystrophies; Nuclear Proteins; Pedigree; Polymerase Chain Reaction; Thymopoietins

1997
Isolation and characterization of the complete mouse emerin gene.
    Mammalian genome : official journal of the International Mammalian Genome Society, 1997, Volume: 8, Issue:5

    Emery-Dreifuss muscular dystrophy (EMD) is an X-linked recessive disorder associated with muscle wasting, contractures, and cardiomyopathy. The responsible emerin gene has recently been identified and found to encode a serine-rich protein similar to lamina-associated protein 2 (LAP2), although the disease mechanism remains obscure. In order to pursue the pathophysiology of this disorder, we report here the isolation and characterization of the complete mouse emerin gene. The emerin cDNA was isolated from murine strain BALB/c, and the emerin gene was isolated from strain 129. The 2.9-kb mouse emerin gene was completely sequenced and found to be composed of 6 exons and encode a protein 73% identical to that of the human protein. Key similarities with LAP2 were found to be conserved, including critical LAP2 phosphorylation sites. Examination of the murine promoter revealed three previously unrecognized cAMP response elements (CRE) conserved between human and mouse. While Northern analysis shows emerin to be widely expressed in the mouse, as it is in humans, these promoter elements may indicate cAMP responsiveness. These data provide the necessary elements to further investigate EMD in a murine system.

    Topics: Amino Acid Sequence; Animals; Base Sequence; Chromosome Mapping; Conserved Sequence; Disease Models, Animal; DNA Primers; DNA-Binding Proteins; DNA, Complementary; Genetic Linkage; Humans; Membrane Proteins; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Muscular Dystrophies; Muscular Dystrophy, Animal; Nuclear Proteins; Rats; Sequence Homology, Amino Acid; Sequence Homology, Nucleic Acid; Species Specificity; Thymopoietins; X Chromosome

1997
Diagnosis of X-linked Emery-Dreifuss muscular dystrophy by protein analysis of leucocytes and skin with monoclonal antibodies.
    Neuromuscular disorders : NMD, 1997, Volume: 7, Issue:1

    The X-linked form of Emery-Dreifuss muscular dystrophy (EDMD) was recently shown to be due to mutations in the STA gene on chromosome Xq28. We have demonstrated a simple test for the diagnosis of this condition, looking for altered expression of the protein, emerin, in leucocytes and skin with a monoclonal antibody. Full-length emerin is completely absent in affected boys from the EDMD families studied. The method has also enabled identification of a female carrier of the disease by reduced levels of the protein on the leucocyte Western blot and a mosaic pattern of expression by immunofluorescence microscopy of the skin biopsy.

    Topics: Adolescent; Antibodies, Monoclonal; Female; Fluorescent Antibody Technique; Genetic Carrier Screening; Genetic Linkage; Humans; Immunologic Tests; Leukocytes; Male; Membrane Proteins; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Nuclear Proteins; Pedigree; Skin; Thymopoietins; X Chromosome

1997
43rd ENMC International Workshop on Emery-Dreifuss Muscular Dystrophy, 22 June 1996, Naarden, The Netherlands.
    Neuromuscular disorders : NMD, 1997, Volume: 7, Issue:1

    Topics: Education; Genes, Dominant; Genetic Linkage; Humans; International Cooperation; Membrane Proteins; Molecular Biology; Muscular Dystrophies; Nuclear Proteins; Thymopoietins; X Chromosome

1997
Inside out, boy you turn me?
    Nature genetics, 1997, Volume: 16, Issue:1

    Topics: Chromosome Inversion; Female; Gene Deletion; Gene Rearrangement; Humans; Membrane Proteins; Muscular Dystrophies; Nuclear Proteins; Thymopoietins; X Chromosome

1997
Emerin deletion reveals a common X-chromosome inversion mediated by inverted repeats.
    Nature genetics, 1997, Volume: 16, Issue:1

    Emery-Dreifuss muscular dystrophy (EMD) is an X-linked disorder characterized by contractures, progressive muscle weakness and cardiomyopathy. The emerin gene, located in human Xq28, is approximately 2 kb in length, is composed of 6 exons and falls within a 219-kb region that has been completely sequenced. Immediately centromeric to emerin is the 26-kb filamin gene (FLN1), composed of 48 exons and encoding the actin-binding protein 280 (refs 7,8). Flanking this 48-kb FLN1/emerin region are two large inverted repeats, each 11.3 kb, that exhibit > 99% sequence identity. The high level of genomic detail in this region allowed us to characterize the first complete emerin gene deletion mutation that also involved a partial duplication of the nearby FLN1 gene. This rearrangement could be explained by mispairing of the large inverted repeats, followed by double recombination among one set of mispaired repeats and internal sequences. Furthermore, our characterization of this rare DNA rearrangement revealed a more common result of the mispairing of these large inverted repeats--recombination contained within the inverted repeats leading to the maintenance of repeat sequence homogeneity and inversion of the 48-kb FLN1/emerin region. The presence of this frequent inversion, found in the heterozygous state in 33% of females, helps to explain the discrepancies observed between the genetic and physical map distances in this region of the X chromosome. It also illustrates the biological insights which can be gleaned by sequencing the human genome.

    Topics: Adult; Blotting, Southern; Chromosome Inversion; Contractile Proteins; Deoxyribonucleases, Type II Site-Specific; Female; Filamins; Gene Deletion; Gene Frequency; Gene Rearrangement; Heterozygote; Humans; Male; Membrane Proteins; Microfilament Proteins; Middle Aged; Models, Genetic; Molecular Sequence Data; Muscular Dystrophies; Nuclear Proteins; Repetitive Sequences, Nucleic Acid; Sequence Analysis, DNA; Thymopoietins; X Chromosome

1997
Direct molecular genetic diagnosis and heterozygote identification in X-linked Emery-Dreifuss muscular dystrophy by heteroduplex analysis.
    Disease markers, 1997, Volume: 13, Issue:2

    X-linked Emery-Dreifuss muscular dystrophy (EMD) is a very rare, relatively benign muscle disorder. The disease is associated with potentially lethal cardiac arrhythmias in affected males and some heterozygous females. X-linked EMD can be genetically distinguished from phenotypically similar autosomal EMD. Heterogenic mutations are identified as the cause of X-linked EMD. We introduced heteroduplex analysis to follow the segregation of heterogenic emerin gene mutations in the families of six unrelated EMD patients. Heteroduplex analysis was proved to be a simple, fast and reliable tool for direct molecular genetic diagnosis of EMD in male patients and identification of heterozygotes even in families where affected males are not available as index cases.

    Topics: DNA Mutational Analysis; Female; Genetic Carrier Screening; Genetic Linkage; Humans; Male; Membrane Proteins; Molecular Sequence Data; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Nuclear Proteins; Nucleic Acid Heteroduplexes; Pedigree; Polymerase Chain Reaction; Thymopoietins; X Chromosome

1997
Six novel mutations in the emerin gene causing X-linked Emery-Dreifuss muscular dystrophy.
    Human mutation, 1997, Volume: 9, Issue:6

    Mutations in the emerin gene, also referred to as the STA- or EMD-gene, have been found to be the cause of X-linked Emery-Dreifuss muscular dystrophy (EMD). For the present study an optimized set of primers was designed to amplify and sequence each of the six emerin gene exons, including the intron/exon boundaries. All emerin gene exons of 30 unrelated EMD patients have been screened by heteroduplex analysis. Aberrant patterns of single exons were found in seven patients. Direct sequencing of the respective exons revealed six novel mutations distributed in the promotor region and exons 3-6 (delta nt -19 to -40; delta AG nt 620-621; ins A nt 895; delta AT nt 908-909; C-->A nt 1420; ins TA nt 1570). By this study, the first mutations in the promotor region and in exon 5 have been identified. Each of the 25 mutations that have been described so far, including those from the present study, abolishes the synthesis of functional emerin. The mutations were submitted to the EMD Mutation database (http://www.path.cam.ac.uk/emd).

    Topics: Base Sequence; DNA Mutational Analysis; DNA Primers; Exons; Female; Genetic Linkage; Humans; Male; Membrane Proteins; Molecular Sequence Data; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Mutation; Nuclear Proteins; Nucleic Acid Heteroduplexes; Polymerase Chain Reaction; Promoter Regions, Genetic; Thymopoietins; X Chromosome

1997
X-linked Emery-Dreifuss muscular dystrophy can be diagnosed from skin biopsy or blood sample.
    Annals of neurology, 1997, Volume: 42, Issue:2

    We have raised an anti-emerin polyclonal antibody against a fusion protein encompassing most of the hydrophilic portion of emerin. Using this antibody, we have analyzed emerin expression in Emery-Dreifuss muscular dystrophy (EDMD) patients and controls, by immunocytochemistry, in skeletal muscle and skin, and by immunoblot, in peripheral blood mononuclear cells and lymphoblasts. Emerin was localized on the surfaces of nuclei in control skeletal muscle and skin but was absent or reduced in patient skeletal muscle, was absent from the skin of patients, and was expressed only in a few nuclei in a patient's mother. Immunoblot of peripheral blood cells from EDMD patients showed absence of the emerin band, altered-size emerin, or a protein of normal molecular mass but slightly reduced quantity. The diagnosis of X-linked EDMD is normally confirmed by genetic analysis of the STA gene coding for emerin. We propose immunocytochemical evaluation of emerin expression in skin biopsies as a sensitive and more convenient tool for diagnosing X-linked EDMD and, in particular, for distinguishing it from the autosomal dominant form. This technique may be applied to suspected EDMD patients, especially sporadic cases or those with incomplete clinical phenotype, and also suspected carriers. Immunoblot of peripheral blood cells is also useful, but it may not unequivocally identify carriers and some patients.

    Topics: Adolescent; Adult; Biomarkers; Biopsy; Child, Preschool; Female; Humans; Immunohistochemistry; Lamins; Leukocytes, Mononuclear; Lymphocytes; Male; Membrane Proteins; Muscle, Skeletal; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Nuclear Proteins; Reference Values; Skin; Thymopoietins; X Chromosome

1997
Heart-specific localization of emerin: new insights into Emery-Dreifuss muscular dystrophy.
    Human molecular genetics, 1997, Volume: 6, Issue:13

    Emery-Dreifuss muscular dystrophy (EDMD) is an X-linked inherited disease characterized by early contracture of the elbows, Achilles tendons and post-cervical muscles, slow progressive muscle wasting and weakness and cardiomyopathy presenting with arrhythmia and atrial paralysis: heart block can eventually lead to sudden death. The EDMD geneencodes a novel ubiquitous protein, emerin, which decorates the nuclear rim of many cell types. Amino acid sequence homology and cellular localization suggested that emerin is a member of the nuclear lamina-associated protein family. These findings did not explain the role of emerin nor account for the skeletal muscle- and heart-specific clinical manifestations associated with the disorder. Now we report that emerin localizes to the inner nuclear membrane, via its hydrophobic C-terminal domain, but that in heart and cultured cardiomyocytes it is also associated with the intercalated discs. We propose a general role for emerin in membrane anchorage to the cytoskeleton. In the nuclear envelope emerin plays a ubiquitous and dispensable role in association of the nuclear membrane with the lamina. In heart its specific localization to desmosomes and fasciae adherentes could account for the characteristic conduction defects described in patients.

    Topics: Arrhythmias, Cardiac; Cell Adhesion; Cytoskeletal Proteins; Cytoskeleton; Desmosomes; Heart Conduction System; Humans; Membrane Proteins; Microscopy, Immunoelectron; Muscle Proteins; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Myocardium; Nuclear Envelope; Nuclear Proteins; Phosphorylation; Protein Processing, Post-Translational; Thymopoietins; X Chromosome

1997
Emerin, deficiency of which causes Emery-Dreifuss muscular dystrophy, is localized at the inner nuclear membrane.
    Neurogenetics, 1997, Volume: 1, Issue:2

    X-linked recessive Emery-Dreifuss muscular dystrophy (EDMD) is an inherited muscle disorder characterized by the clinical triad of progressive wasting of humero-peroneal muscles, early contractures of the elbows, Achilles tendons and postcervical muscles, and cardiac conduction block with a high risk of sudden death. The gene for EDMD on Xq28 encodes a novel protein named emerin that localizes at the nuclear membrane of skeletal, cardiac and smooth muscles and some other non-muscle tissues. To investigate a possible physiological role for emerin, we examined the ultrastructural localization of the protein in human skeletal muscle and HeLa cells, using ultrathin cryosections. We found that the immune-labeled colloidal gold particles were localized on the nucleoplasmic surface of the inner nuclear membrane, but not on the nuclear pore. Emerin stayed on the cytoplasmic surface of the nuclear lamina, even after detergent treatment that solubilizes membrane lipids and washes out membrane proteins. These results suggest that emerin anchors at the inner nuclear membrane through the hydrophobic stretch, and protrudes from the hydrophilic region to the nucleoplasm where it interacts with the nuclear lamina. We speculate that emerin contributes to maintain the nuclear structure and stability, as well as nuclear functions, particularly in muscle tissues that have severe stress with rigorous contraction-relaxation movements and calcium flux.

    Topics: Cell Nucleus; HeLa Cells; Humans; Immunoblotting; Immunohistochemistry; Membrane Proteins; Microscopy, Confocal; Microscopy, Electron; Muscle, Skeletal; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Nuclear Envelope; Nuclear Proteins; Thymopoietins

1997
Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy.
    Nature genetics, 1996, Volume: 12, Issue:3

    Mutations in the STA gene at the Xq28 locus have been found in patients with X-linked Emery-Dreifuss muscular dystrophy (EDMD). This gene encodes a hitherto unknown protein named 'emerin'. To elucidate the subcellular localization of emerin, we raised two antisera against synthetic peptide fragments predicted from emerin cDNA. Using both antisera, we found positive nuclear membrane staining in skeletal, cardiac and smooth muscles in the normal controls and in patients with neuromuscular diseases other than EDMD. In contrast, a deficiency in immunofluorescent staining of skeletal and cardiac muscle from EDMD patients was observed. A 34 kD protein is immunoreactive with the antisera--the protein is equivalent to that predicted for emerin. Together, our findings suggest the specific deficiency of emerin in the nuclear membrane of muscle cells in patients with EDMD.

    Topics: Adolescent; Adult; Amino Acid Sequence; Base Sequence; DNA; Fluorescent Antibody Technique, Indirect; Humans; Immunoblotting; Male; Membrane Proteins; Molecular Sequence Data; Muscles; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Mutation; Nuclear Envelope; Nuclear Proteins; Subcellular Fractions; Thymopoietins

1996
A novel emerin mutation in a Japanese patient with Emery-Dreifuss muscular dystrophy.
    Human genetics, 1996, Volume: 97, Issue:5

    Sequencing of the STA gene in a patient with Emery-Dreifuss muscular dystrophy showed a 1-bp deletion of C at nucleotide 672 or 673. This deletion causes a frameshift, changing the amino acid sequence (amino acids 206-235) and generating an early stop codon.

    Topics: Adolescent; Amino Acid Sequence; Base Composition; Base Sequence; Child; DNA Primers; Exons; Humans; Introns; Japan; Male; Membrane Proteins; Molecular Sequence Data; Muscular Dystrophies; Nuclear Proteins; Polymerase Chain Reaction; Protein Conformation; Reference Values; Sequence Deletion; Thymopoietins; X Chromosome

1996
The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein.
    Human molecular genetics, 1996, Volume: 5, Issue:6

    A large fragment of emerin cDNA was prepared by PCR and expressed as a recombinant protein in Escherichia coli. Using this as immunogen, we prepared a panel of 12 monoclonal antibodies which recognise at least four different epitopes on emerin in order to ensure that emerin can be distinguished from non-specific cross-reacting proteins. All the mAbs recognised a 34 kDa protein in all tissues tested, though minor emerin-related bands were also detected in some tissues. Immunofluorescence microscopy showed that emerin is located at the nuclear rim in all tissues examined. A muscle biopsy from an Emery-Dreifuss muscular dystrophy (EMDM) patient showed complete absence of emerin by both Western blotting and immunohistochemistry, suggesting a simple diagnostic antibody test for EDMD families. Biochemical fractionation of brain and liver tissues showed that emerin was present in nuclei purified by centrifugation through 65% sucrose and was absent from soluble fractions (post-100,000 g). From these results, together with sequence and structural homologies between emerin, thymopoietins and the nuclear lamina-associated protein, LAP2, we suggest that emerin will prove to be one member of a family of inner nuclear membrane proteins.

    Topics: Adult; Animals; Antibodies, Monoclonal; Cell Nucleus; Epitope Mapping; Fetus; Humans; Membrane Proteins; Muscles; Muscular Dystrophies; Nuclear Proteins; Rabbits; Recombinant Fusion Proteins; Thymopoietins

1996
Identification of new mutations in the Emery-Dreifuss muscular dystrophy gene and evidence for genetic heterogeneity of the disease.
    Human molecular genetics, 1995, Volume: 4, Issue:10

    The Emery-Dreifuss Muscular Dystrophy (EDMD) is an X-linked recessive muscular disorder characterized by early contractures of the elbows, Achilles tendons and postcervical muscles, slowly progressing muscle wasting and weakness and a cardiomyopathy characterized by conduction defects. Heart block is a frequent cause of death. Finding of mutations in one of the transcripts in the critical region in distal Xq28 led to the identification of the gene responsible for the disease. We now report the sequence of the gene which is 2100 bp long and the development of a set of primers to amplify and sequence the gene from patients' DNA. Eight unrelated X-linked familial cases were studied and they all carried different mutations, showing that lack of emerin in cardiac and skeletal muscle is the cause of the X-linked disease. No mutations were found in a family where the female carrier was affected nor in a sporadic case with a well established diagnosis of EDMD. Our findings suggest genetic heterogeneity of EDMD, and that at least two genes, the X-linked STA gene and one unidentified autosomal gene, are responsible for the disease.

    Topics: Base Sequence; Cause of Death; Chromosome Mapping; DNA Primers; DNA, Complementary; Female; Genetic Carrier Screening; Heart Block; Humans; Male; Membrane Proteins; Molecular Sequence Data; Muscular Dystrophies; Mutation; Nuclear Proteins; Polymerase Chain Reaction; Thymopoietins; X Chromosome

1995
SSCP detection of novel mutations in patients with Emery-Dreifuss muscular dystrophy: definition of a small C-terminal region required for emerin function.
    Human molecular genetics, 1995, Volume: 4, Issue:10

    Topics: Base Sequence; Codon; DNA Primers; Exons; Humans; Membrane Proteins; Molecular Sequence Data; Muscular Dystrophies; Nuclear Proteins; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Reference Values; Thymopoietins; Transcription, Genetic

1995
Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy.
    Nature genetics, 1994, Volume: 8, Issue:4

    Emery-Dreifuss muscular dystrophy (EDMD) is an X-linked recessive disorder characterized by slowly progressing contractures, wasting of skeletal muscle and cardiomyopathy. Heart block is a frequent cause of death. The disease gene has been mapped to distal Xq28. Among many genes in this region, we selected eight transcripts expressed at high levels in skeletal muscle, heart and/or brain as the best candidates for the disease. We now report, in all five patients studied, unique mutations in one of the genes, STA: these mutations result in the loss of all or part of the protein. The EDMD gene encodes a novel serine-rich protein termed emerin, which contains a 20 amino acid hydrophobic domain at the C terminus, similar to that described for many membrane proteins of the secretory pathway involved in vesicular transport.

    Topics: Amino Acid Sequence; Base Sequence; Cells, Cultured; DNA Mutational Analysis; DNA, Complementary; Genetic Linkage; Humans; Membrane Proteins; Molecular Sequence Data; Muscular Dystrophies; Muscular Dystrophy, Emery-Dreifuss; Nuclear Proteins; RNA, Messenger; Sequence Homology, Amino Acid; Thymopoietins; X Chromosome

1994